journal article·2024-07Open access

Heterogeneous‐Structure‐Based AuNBs@TiO2 Nano‐Photosensitizers for Computed Tomography Imaging Guided NIR‐II Photodynamic Therapy and Cancer Metastatic Prevention

Xinfeng Tang, Yi Wu, Yanqiong Shen, Zhiqi Huang, Wei Jiang, Yingming Zhao, Weifu Lv, Yanhua Zhu

Advanced Healthcare Materials· Volume 13· Issue 18

Abstract

Abstract Photodynamic therapy (PDT) is a minimally invasive cancer treatment that, despite its significant attention, faces limitations in penetration depth, which restrict its effectiveness. Herein, it is found that gold nanobipyramid (AuNBs) coated with TiO2 can form a core–shell heterogeneous structure (AuNBs@TiO2) with strong absorption at second near infrared (NIR‐II) region. A substantial quantity of reactive oxygen species (ROS), including singlet oxygen (1O2), superoxide anion radicals, and hydroxyl radicals, can be rapidly generated when subjecting the AuNBs@TiO2 aqueous suspension to 1064 nm laser irradiation. The quantum yield for sensitization of 1O2 by AuNBs@TiO2 is 0.36 at 1064 nm light excitation. In addition, the Au element as high‐Z atoms in the nanosystem can improve the ability of computed tomographic (CT) imaging. As compared to commercial iohexol, the AuNBs@TiO2 nanoparticle exhibits significantly better CT imaging effect, which can be used to guide PDT. In addition, the nano‐photosensitizer shows a remarkable therapeutic effect against established solid tumors and prevents tumor metastasis and potentiates immune checkpoint blockade therapy. More importantly, here the great potentials of AuNBs@TiO2 are highlighted as a theranostic platform for CT‐guided cancer photodynamic immunotherapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis · Luminescence and Fluorescent Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine University of Science and Technology of China Hefei 230001 China

Institute of Health and Medicine Hefei Comprehensive National Science Center Hefei 230051 China

Hefei National Laboratory for Physical Sciences at the Microscale, School of Chemistry and Materials Science University of Science and Technology of China Hefei 230026 China

The CAS Key Laboratory of Innate Immunity and Chronic Disease, Division of Life Sciences and Medicine University of Science and Technology of China Hefei 230027 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China

References (45)

Show source-provided references
1. 10.1002/smll.20220477810.1002/smll.202204778 ↗
2. 10.1021/acs.chemrev.1c0038110.1021/acs.chemrev.1c00381 ↗
3. 10.1016/j.ccr.2021.21388810.1016/j.ccr.2021.213888 ↗
4. 10.1016/j.ccr.2023.21532410.1016/j.ccr.2023.215324 ↗
5. 10.1002/smll.20220799510.1002/smll.202207995 ↗
6. 10.1016/j.nantod.2023.10181610.1016/j.nantod.2023.101816 ↗
7. 10.1016/j.biomaterials.2022.12191810.1016/j.biomaterials.2022.121918 ↗
8. 10.1039/B915149B10.1039/B915149B ↗
9. 10.1021/jacs.0c1233010.1021/jacs.0c12330 ↗
10. 10.1002/adhm.20230026310.1002/adhm.202300263 ↗
11. 10.1021/acsnano.1c1056510.1021/acsnano.1c10565 ↗
12. 10.1016/j.msec.2017.03.12910.1016/j.msec.2017.03.129 ↗
13. 10.1002/anie.20190871210.1002/anie.201908712 ↗
14. 10.1186/s12951-018-0432-410.1186/s12951-018-0432-4 ↗
15. 10.1016/j.bios.2016.03.07210.1016/j.bios.2016.03.072 ↗
16. 10.1016/j.biomaterials.2016.04.00610.1016/j.biomaterials.2016.04.006 ↗
17. 10.1016/j.cej.2018.01.08110.1016/j.cej.2018.01.081 ↗
18. 10.1002/anie.20190517110.1002/anie.201905171 ↗
19. 10.1002/adma.20170374010.1002/adma.201703740 ↗
20. 10.1021/acsnano.8b0283010.1021/acsnano.8b02830 ↗
21. 10.1088/2515-7655/abf8f710.1088/2515-7655/abf8f7 ↗
22. 10.1039/C6CS00616G10.1039/C6CS00616G ↗
23. 10.1002/adfm.20230596510.1002/adfm.202305965 ↗
24. 10.1002/smll.20220064610.1002/smll.202200646 ↗
25. 10.1039/C7NR07927C10.1039/C7NR07927C ↗
26. 10.1007/s12274-018-2075-z10.1007/s12274-018-2075-z ↗
27. 10.1002/adma.20160415710.1002/adma.201604157 ↗
28. 10.1002/adma.20140070310.1002/adma.201400703 ↗
29. 10.1016/j.biomaterials.2014.03.06510.1016/j.biomaterials.2014.03.065 ↗
30. 10.1002/advs.20210007410.1002/advs.202100074 ↗
31. 10.1002/smll.20130271910.1002/smll.201302719 ↗
32. 10.1039/C6NR09046J10.1039/C6NR09046J ↗
33. Gourdon L. · Chem. Rev. · 2022 · 51 · 1167
34. 10.1021/acsaom.3c0019410.1021/acsaom.3c00194 ↗
35. 10.1002/adfm.20211306510.1002/adfm.202113065 ↗
36. 10.1021/jacs.2c0787210.1021/jacs.2c07872 ↗
37. 10.1016/j.biomaterials.2023.12239210.1016/j.biomaterials.2023.122392 ↗
38. 10.1002/anie.20191142910.1002/anie.201911429 ↗
39. 10.1039/C4EE01787K10.1039/C4EE01787K ↗
40. 10.7150/thno.7962510.7150/thno.79625 ↗
41. 10.1002/VIW.2020014910.1002/VIW.20200149 ↗
42. 10.1002/smll.20210284810.1002/smll.202102848 ↗
43. 10.1016/j.biomaterials.2021.12123710.1016/j.biomaterials.2021.121237 ↗
44. 10.1016/j.jhazmat.2020.12338210.1016/j.jhazmat.2020.123382 ↗
45. 10.1021/acsami.6b0581710.1021/acsami.6b05817 ↗